Table 1.
Characteristics | Study cohort n = 54 |
---|---|
Age, years | 59.2 ± 10.2 (34–80) |
Height, cm | 162.5 ± 7.8 (148–180) |
Weight, kg | 65.2 ± 9.7 (43–85) |
BMI, kg/m2 | 24.7 ± 3.0 (17.0–34.2) |
SBP, mmHg | 170.8 ± 21.8 (132–222) |
DBP, mmHg | 80.3 ± 8.6 (62–98) |
ASA I/ASA II | 19/35 |
Male/female | 27/27 |
Hypertension | 15 (28%) |
Atherosclerosis | 11 (20%) |
Diabetes mellitus | 3 (6%) |
Ephedrine use | 3 (6%) |
Propofol, mg | 149.9 ± 32.3 (81–221) |
Sufentanil, µg | 26.6 ± 4.1 (20–35) |
Rocuronium, mg | 53.0 ± 10.1 (40–100) |
SBPV, % | 18.3 ± 4.4 (9.7–28.0) |
DBPV, % | 16.1 ± 5.4 (8.3–40.4) |
PWTT, ms | 96.8 ± 17.2 (61–132) |
Data presented as mean ± SD (range) or n of patients (%).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ASA, American Society of Anesthesiologists; SBPV, systolic blood pressure variability; DBPV, diastolic blood pressure variability; PWTT, pulse wave transit time.